Research
Institutional Investors Find Calm Amid Post-Election Chaos
The markets see stability ahead, despite a delayed election result, Senate runoff races, and voter fraud claims from the president.
Tag: vaccine
Will Snags with New Washington Stimulus Squelch the Economy and Stocks?
Not really, says UBS’s Haefele, sounding optimistic on vaccines and possible fresh aid in 2021.
Market Moves
Ackman Bets on a Pandemic Bond Wipeout—Again
His new bearish investment is similar to the one in March that earned him a $2.6 billion jackpot.
Market Moves
From Here, Recovery Will be ‘Tougher,’ But Good Investments Persist
So say two savants from Principal Financial, at CIO’s Summit.
Coronavirus - COVID-19
Wells Fargo: 2020 Market Is Too Iffy to Put New Money In
The election and the virus could trigger another stock slump, says strategist Christopher Harvey.
Market Moves
Goldman’s 10 Reasons That the Bull Market Will Resume
An array of forces will juice stocks anew and the early-September drop is just a correction, the firm argues.
Market Moves
Good Vaccine News Has Immediate Impact on the Stock Market
A quarter of the S&P 500’s rise since May is linked to positive developments on a virus inoculation, UBS says.
Market Moves
Rebound Rally Often Has a Dip—And That Would Come Around Election Day
A bouncing-back S&P 500 tends to drop by 5%, two-plus months after setting a new record, says CFRA’s Sam Stovall. Would this impact the presidential race?
Market Moves
This Rally Will Last a Long Time, Invesco Predicts
The economy and the stock market should be able to overcome the virus, say the firm’s strategists.
Risk
BofA: The 3 Market Risks You Haven’t Thought About
One relates to the pandemic, one to politics, and one to federal stimulus.
Coronavirus - COVID-19
No Vaccine? Then Look for 18 Months of Shutdowns
Fed’s Kashkari warns of new flare-ups that could push economy back into an induced coma.